Skip to main content
    C

    Castle Biosciences Inc (CSTL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $33.79
    -0.71 (-2.06%)

    Market Cap: $1.04B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Castle Biosciences Inc (CSTL) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Castle Biosciences are Personalis (PSNL), Fulgent Genetics (FLGT) and Myriad Genetics (MYGN). By market cap, Castle Biosciences ranks 8th of the 13 companies on this page; GRAIL, LLC (GRAL) is the largest at $5.21B. The median P/E of the 3 companies with a P/E is 48.2x.

    Peer Comparison

    CSTL's ROIC of -5.4% is above the peer median of -12.1%, and its revenue growth of 23.9% is above the median of 9.4%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Castle Biosciences (CSTL)$1.04BN/A2.7x-6.1%-5.4%23.9%0.00%
    Personalis Inc (PSNL)$1.70BN/A20.9x-147.7%N/A76.6%0.00%
    Fulgent Genetics Inc (FLGT)$688.98MN/A2.0x-27.5%-12.1%7.5%0.00%
    Myriad Genetics Inc (MYGN)$542.92MN/A0.7x-16.1%-29.5%-1.5%0.00%
    NeoGenomics Inc (NEO)$2.07B228.9x2.6x-4.1%-2.5%11.4%0.00%
    Veracyte Inc (VCYT)$1.96B13.3x3.3x21.8%8.2%15.1%0.00%
    Opko Health Inc (OPK)$1.25BN/A2.4x-22.6%-6.2%15.9%0.00%
    CareDx Inc (CDNA)$4.09B48.2x6.4x25.9%N/A39.3%0.00%
    GRAIL, LLC (GRAL)$5.21BN/A29.6x-243.8%N/A3.7%0.00%
    Adaptive Biotechnologies Corp (ADPT)$4.70BN/A15.0x-23.7%N/A-10.7%0.00%
    MDxHealth SA (MDXH)$13.75MN/AN/A-38.3%-40.5%-17.2%0.00%
    Solid Biosciences LLC (SLDB)$763.42MN/AN/A0.0%N/A-100.0%0.00%
    Beta Bionics, Inc. Common Stock (BBNX)$892.71MN/A5.6x-65.3%-18.0%30.3%0.00%
    Peer median$1.48B48.2x4.4x-23.1%-12.1%9.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Castle Biosciences, ranked by how closely their business, size, sector and industry match. The largest group, 10 of the 12, is in Diagnostics & Research; the other 2 span 2 industries.

    CompanyAboutPeers
    Personalis Inc (PSNL)Diagnostics & Research
    Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
    PSNL competitors
    Fulgent Genetics Inc (FLGT)Diagnostics & Research
    Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information.
    FLGT competitors
    Myriad Genetics Inc (MYGN)Diagnostics & Research
    Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized...
    MYGN competitors
    NeoGenomics Inc (NEO)Diagnostics & Research
    NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia.
    NEO competitors
    Veracyte Inc (VCYT)Diagnostics & Research
    Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
    VCYT competitors
    Opko Health Inc (OPK)Diagnostics & Research
    OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico...
    OPK competitors
    CareDx Inc (CDNA)Diagnostics & Research
    CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally.
    CDNA competitors
    GRAIL, LLC (GRAL)Diagnostics & Research
    GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics...
    GRAL competitors
    Adaptive Biotechnologies Corp (ADPT)Diagnostics & Research
    Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
    ADPT competitors
    MDxHealth SA (MDXH)Diagnostics & Research
    MDxHealth SA is a prominent biotechnology company focused on precision diagnostics that enhance cancer management, particularly in prostate and bladder cancers.
    MDXH competitors
    Solid Biosciences LLC (SLDB)Biotechnology
    Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States.
    SLDB competitors
    Beta Bionics, Inc. Common Stock (BBNX)Medical Devices
    Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development...
    BBNX competitors

    Frequently Asked Questions About CSTL

    Who are Castle Biosciences' main competitors?

    The companies most similar to Castle Biosciences include Personalis (PSNL), Fulgent Genetics (FLGT), Myriad Genetics (MYGN), NeoGenomics (NEO) and Veracyte (VCYT), listed from the closest match.

    Who is Castle Biosciences' biggest competitor?

    GRAIL, LLC (GRAL) is the largest of the similar companies at $5.21B; Personalis (PSNL) is the closest match by business profile, size, sector and industry.

    How does CSTL stock compare with its competitors?

    CSTL's P/S is 2.7x against a peer median of 4.4x; its net margin is -6.1% against a peer median of -23.1%.

    Which of Castle Biosciences' competitors pays a higher dividend?

    Castle Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Castle Biosciences bigger than its competitors?

    No. Castle Biosciences is 8th by market cap among the 13 companies on this page; the largest is GRAIL, LLC (GRAL) at $5.21B.